Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.41

€0.41

2.910%
0.0115
2.910%
-
 
22:25 / Tradegate WKN: A3EKSZ / Name: Onco-innovations Ltd. / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Onco-innovations Ltd. Stock

There is an upward development for Onco-innovations Ltd. compared to yesterday, with an increase of €0.012 (2.910%).
Our community identified positive and negative aspects for Onco-innovations Ltd. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Onco-innovations Ltd. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Onco-innovations Ltd. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010

Vancouver, Canada – June 30, 2026 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce, further to its news

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

Vancouver, Canada – June 26, 2026 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) announces the initiation of hepatocyte and

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

Vancouver, Canada - June 23, 2026 - Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that it has entered